Literature DB >> 8443404

Lipid-associated sialic acid levels in human breast cyst fluids.

F Mannello1, G Bocchiotti, R Troccoli, G Gazzanelli.   

Abstract

Benign mammary gross cystic disease is the most common breast lesion. Women with apocrine changes of epithelium lining the cysts are at higher risk for developing breast cancer than the normal female population. Sialic acid has drawn considerable interest because of carbohydrate aberrations in malignant cells. The current investigation determined the concentrations of lipid-associated sialic acid (LASA) in 62 breast cyst fluids and sera. Data analyses show a significant increase in the mean values of LASA in metabolically active apocrine cysts when compared to the cysts with Na+/K+ > 3 (flattened cysts) (p < 0.001). The greater LASA levels in cyst fluids with lower intracystic Na+/K+ ratios could represent an altered expression of biosynthetic activity of the surrounding apocrine cell surface sialoglycolipid metabolism, providing a possible explanation of why women with apocrine cysts may be at greater cancer risk and being useful in further studies on functional stage changes in the cysts and their relationship to breast cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 8443404     DOI: 10.1007/bf01961249

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

1.  Evaluation of sialic acid concentrations in serum for the diagnosis and staging of breast cancer.

Authors:  W M Riley; C Tautu; G Verazin; J Gregory; S Josiah; J J Prorok; J A Alhadeff
Journal:  Clin Chem       Date:  1990-01       Impact factor: 8.327

2.  Breast cancer in women subsequent to cystic disease of the breast.

Authors:  U Veronesi; G Pizzocaro
Journal:  Surg Gynecol Obstet       Date:  1968-03

3.  Hormones in breast fluid.

Authors:  D P Rose
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

4.  Serum lipid-bound sialic acid as a marker in breast cancer.

Authors:  A M Dnistrian; M K Schwartz; N Katopodis; A A Fracchia; C C Stock
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

5.  Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein.

Authors:  D E Haagensen; G Mazoujian; W G Dilley; C E Pedersen; S J Kister; S A Wells
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

6.  GCDFP-70 protein in cyst fluid identified as albumin and used to classify cysts in women with breast gross cystic disease.

Authors:  M Balbín; F Vizoso; L M Sánchez; R Venta; A Ruibal; A Fueyo; C López-Otín
Journal:  Clin Chem       Date:  1991-04       Impact factor: 8.327

7.  The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease.

Authors:  J M Dixon; A B Lumsden; W R Miller
Journal:  Eur J Cancer Clin Oncol       Date:  1985-09

8.  Classification of human breast cysts according to electrolyte and androgen conjugate composition.

Authors:  W R Miller; J M Dixon; W N Scott; A P Forrest
Journal:  Clin Oncol       Date:  1983-09

9.  Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.

Authors:  M C Plucinsky; W M Riley; J J Prorok; J A Alhadeff
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

Review 10.  Malignant cell glycoproteins and glycolipids.

Authors:  J A Alhadeff
Journal:  Crit Rev Oncol Hematol       Date:  1989       Impact factor: 6.312

View more
  1 in total

1.  Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; G Bianchi; F Marcheggiani; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.